Postpartum hemorrhage is the most common cause of maternal mortality in Russia. Production of the hormonal drug will be carried out by the PSK Pharma company.
Its active ingredient is carbetocin. Earlier it was reported that 240 million rubles would be allocated to the Moscow region for screening newborns. The head of the department, Ekaterina Zinovieva, is quoted in the message as saying the move is of great importance for the safety of life and health of patients.